-
Jefferies Raises PT On Pharmaceutical Product Development
Thursday, January 20, 2011 - 8:31am | 28Jefferies & Company has raised the price target on Pharmaceutical Product Development (NASDAQ: PPDI) from $29 to $32 and maintains its Buy rating.
-
Citigroup Ups ILMN To Buy
Thursday, January 20, 2011 - 8:02am | 49Analysts at Citigroup upgrade Illumina Inc (NASDAQ: ILMN) from “hold” to “buy.” The target price for ILMN has been raised from $56 to $85. ILMN shares fell 2.10% to close at $69.48 yesterday. More Analyst Ratings here
-
Citigroup Raises PT On Illumina
Thursday, January 20, 2011 - 7:49am | 25Citigroup has raised the price target on Illumina (NASDAQ: ILMN) from $56 to $85 and maintains its Buy rating.
-
PPD Sees 2011 EPS of $1.53 to $1.69
Wednesday, January 19, 2011 - 5:31pm | 84PPD, Inc. (Nasdaq: PPDI) today reported its projected 2011 financial guidance. PPD anticipates that net revenue, excluding reimbursed out-of-pocket expenses, for the full year 2011 will be in the range of $1.48 to $1.58 billion. The company expects diluted earnings per share for the full year 2011...
-
NASDAQ Stocks Hitting 52-Week Highs (NATI, GENE, TITN, SGC)
Wednesday, January 19, 2011 - 11:59am | 144National Instruments Corporation (NASDAQ: NATI) shares gained 0.55% to create a new 52-week high of $40.18. NATI is scheduled to report its Q4 results on January 25. Genetic Technologies Ltd (NASDAQ: GENE) shares surged 83.63% to create a new 52-week high of $6.17. GENE had $3.28 million in total...
-
Genetic Technologies Spikes 78% Higher (GENE)
Wednesday, January 19, 2011 - 11:53am | 29Genetic Technologies (NASDAQ: GENE) spikes 78% higher today on heavy volume. At last check shares were trading at $6, up 78% from yesterday's close.
-
Morning Market Movers (GENE, PTX, CIMT, GENT)
Wednesday, January 19, 2011 - 11:14am | 125Genetic Technologies Ltd (NASDAQ: GENE) shares surged 26.19% to $4.24 at 10:00 am. GENE had $3.28 million in total cash and $379.71 thousand in total debt for the recent quarter. Pernix Therapeutics Holdings Inc (AMEX: PTX) jumped 24.70% to $9.85. PTX reported that the US Food and Drug...
-
Exane BNP Paribas Downs QGEN To Neutral
Wednesday, January 19, 2011 - 7:23am | 41Analysts at Exane BNP Paribas downgrade Qiagen NV (NASDAQ: QGEN) from “outperform” to “neutral.” QGEN shares fell 0.16% to close at $19.24 yesterday. More Analyst Ratings here
-
Architecture Billings Index Continues Positive Momentum, Reaches Pre-Recession Level in Dec.
Wednesday, January 19, 2011 - 12:11am | 332Washington, D.C. – January 19, 2010 – "On the heels of its highest mark since 2007, the Architecture Billings Index (ABI) jumped more than two points in December. As a leading economic indicator of construction activity, the ABI reflects the approximate nine to twelve month lag time between...
-
Market Longs Are Strong 01-18-2011
Tuesday, January 18, 2011 - 7:22pm | 874Cusick's Corner The market has held up again and is potentially setting up a nice upside challenge. This is the blow off that we have been waiting for and the catalyst could be AAPL's earnings. While the sustainability of a blow off run will come into question, the mere fact is that the longs are...
-
Affymetrix's Rice Genotyping Test - Analyst Blog
Tuesday, January 18, 2011 - 7:01pm | 392California-based genetic products maker Affymetrix Inc (AFFX) has announced the launch of its first high-density rice genotyping array at the Plant and Animal Genome XIX Conference in San Diego. The test, dubbed GeneChip Rice 44K SNP Genotyping Array, will offer an affordable, high-quality method...
-
Affymetrix's Rice Genotyping Test - Analyst Blog
Tuesday, January 18, 2011 - 6:37pm | 392California-based genetic products maker Affymetrix Inc (AFFX) has announced the launch of its first high-density rice genotyping array at the Plant and Animal Genome XIX Conference in San Diego. The test, dubbed GeneChip Rice 44K SNP Genotyping Array, will offer an affordable, high-quality method...
-
Nektar Therapeutics Announces Public Offering
Tuesday, January 18, 2011 - 5:07pm | 79Nektar Therapeutics (Nasdaq: NKTR) today announced that it is offering to sell shares of its common stock in a firm commitment underwritten public offering. Jefferies & Company, Inc. is acting as sole book-running manager in this offering. The public offering is subject to market conditions...
-
Accelr8 not Commenting on Unusual market Activity
Tuesday, January 18, 2011 - 3:08pm | 52In view of the unusual market activity in the stock of Accelr8 Technology Corp. (NYSE: AXK), the NYSE has contacted the company in accordance with its usual practice; the company stated that its policy is not to comment on unusual market activity or rumors.
-
MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International
Tuesday, January 18, 2011 - 9:25am | 106MonoSol Rx, LLC filed an amended patent infringement and false marking lawsuit today against BioDelivery Sciences International, Inc. (NASDAQ: BDSI), MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc. in the United States District Court for the District of New Jersey. MonoSol Rx's...